SENS Senseonics Holdings, Inc.
Senseonics Holdings, Inc. (SENS) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.48 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +35.6% since its last earnings release on August 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Senseonics Holdings, Inc.
Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology.
Sector
Healthcare
Industry
Medical Appliances/Equipment